company background image
CRDA

Croda InternationalLSE:CRDA Stock Report

Market Cap

UK£12.8b

7D

5.1%

1Y

48.9%

Updated

25 Oct, 2021

Data

Company Financials +
CRDA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance3/6
Financial Health4/6
Dividends4/6

CRDA Overview

Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America.

Croda International Competitors

Johnson Matthey

LSE:JMAT

UK£5.2b

Victrex

LSE:VCT

UK£2.0b

Synthomer

LSE:SYNT

UK£2.0b

Elementis

LSE:ELM

UK£789.1m

Price History & Performance

Summary of all time highs, changes and price drops for Croda International
Historical stock prices
Current Share PriceUK£93.00
52 Week HighUK£58.43
52 Week LowUK£93.58
Beta0.53
1 Month Change5.20%
3 Month Change12.51%
1 Year Change48.94%
3 Year Change93.24%
5 Year Change159.54%
Change since IPO5,704.98%

Recent News & Updates

Oct 09
Is Croda International Plc (LON:CRDA) Worth UK£82.6 Based On Its Intrinsic Value?

Is Croda International Plc (LON:CRDA) Worth UK£82.6 Based On Its Intrinsic Value?

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Croda International...

Sep 24
Croda International (LON:CRDA) Seems To Use Debt Quite Sensibly

Croda International (LON:CRDA) Seems To Use Debt Quite Sensibly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

CRDAGB ChemicalsGB Market
7D5.1%2.5%-0.3%
1Y48.9%32.8%23.2%

Return vs Industry: CRDA exceeded the UK Chemicals industry which returned 32.8% over the past year.

Return vs Market: CRDA exceeded the UK Market which returned 23.2% over the past year.

Price Volatility

Is CRDA's price volatile compared to industry and market?
CRDA volatility
CRDA Beta0.53
Industry Beta0.86
Market Beta1

Stable Share Price: CRDA is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: CRDA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19255,684Steve Footshttps://www.croda.com

Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries.

Croda International Fundamentals Summary

How do Croda International's earnings and revenue compare to its market cap?
CRDA fundamental statistics
Market CapUK£12.81b
Earnings (TTM)UK£246.80m
Revenue (TTM)UK£1.65b

52.2x

P/E Ratio

7.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CRDA income statement (TTM)
RevenueUK£1.65b
Cost of RevenueUK£859.30m
Gross ProfitUK£792.10m
ExpensesUK£545.30m
EarningsUK£246.80m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Mar 01, 2022

Earnings per share (EPS)1.78
Gross Margin47.97%
Net Profit Margin14.94%
Debt/Equity Ratio53.4%

How did CRDA perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

52%

Payout Ratio

Valuation

Is Croda International undervalued compared to its fair value and its price relative to the market?

52.16x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: CRDA (£92.58) is trading above our estimate of fair value (£61.88)

Significantly Below Fair Value: CRDA is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CRDA is poor value based on its PE Ratio (51.9x) compared to the UK Chemicals industry average (23.3x).

PE vs Market: CRDA is poor value based on its PE Ratio (51.9x) compared to the UK market (21.3x).


Price to Earnings Growth Ratio

PEG Ratio: CRDA is poor value based on its PEG Ratio (5.8x)


Price to Book Ratio

PB vs Industry: CRDA is overvalued based on its PB Ratio (7.8x) compared to the GB Chemicals industry average (2.5x).


Future Growth

How is Croda International forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?

8.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRDA's forecast earnings growth (8.9% per year) is above the savings rate (0.9%).

Earnings vs Market: CRDA's earnings (8.9% per year) are forecast to grow slower than the UK market (12.8% per year).

High Growth Earnings: CRDA's earnings are forecast to grow, but not significantly.

Revenue vs Market: CRDA's revenue (5.8% per year) is forecast to grow faster than the UK market (5% per year).

High Growth Revenue: CRDA's revenue (5.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CRDA's Return on Equity is forecast to be low in 3 years time (17.4%).


Past Performance

How has Croda International performed over the past 5 years?

1.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CRDA has high quality earnings.

Growing Profit Margin: CRDA's current net profit margins (14.9%) are lower than last year (15.5%).


Past Earnings Growth Analysis

Earnings Trend: CRDA's earnings have grown by 1.7% per year over the past 5 years.

Accelerating Growth: CRDA's earnings growth over the past year (19.1%) exceeds its 5-year average (1.7% per year).

Earnings vs Industry: CRDA earnings growth over the past year (19.1%) underperformed the Chemicals industry 30.4%.


Return on Equity

High ROE: CRDA's Return on Equity (14.9%) is considered low.


Financial Health

How is Croda International's financial position?


Financial Position Analysis

Short Term Liabilities: CRDA's short term assets (£831.4M) exceed its short term liabilities (£419.2M).

Long Term Liabilities: CRDA's short term assets (£831.4M) do not cover its long term liabilities (£1.1B).


Debt to Equity History and Analysis

Debt Level: CRDA's debt to equity ratio (53.4%) is considered high.

Reducing Debt: CRDA's debt to equity ratio has reduced from 96.2% to 53.4% over the past 5 years.

Debt Coverage: CRDA's debt is well covered by operating cash flow (33.3%).

Interest Coverage: CRDA's interest payments on its debt are well covered by EBIT (19.2x coverage).


Balance Sheet


Dividend

What is Croda International current dividend yield, its reliability and sustainability?

1.02%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CRDA's dividend (1.03%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.4%).

High Dividend: CRDA's dividend (1.03%) is low compared to the top 25% of dividend payers in the UK market (4.06%).


Stability and Growth of Payments

Stable Dividend: CRDA's dividends per share have been stable in the past 10 years.

Growing Dividend: CRDA's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (52.1%), CRDA's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CRDA's dividends in 3 years are forecast to be well covered by earnings (43.5% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.8yrs

Average management tenure


CEO

Steve Foots (52 yo)

9.75yrs

Tenure

UK£1,549,437

Compensation

Mr. Stephen Edward Foots, also known as Steve, serves as the Chief Executive Officer of Croda International plc since January 1, 2012 and its Executive Director since July 2010. Mr. Foots serves as the Pre...


CEO Compensation Analysis

Compensation vs Market: Steve's total compensation ($USD2.13M) is below average for companies of similar size in the UK market ($USD3.89M).

Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CRDA's management team is seasoned and experienced (5.8 years average tenure).


Board Members

Experienced Board: CRDA's board of directors are considered experienced (3.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CRDA insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.3%.


Top Shareholders

Company Information

Croda International Plc's employee growth, exchange listings and data sources


Key Information

  • Name: Croda International Plc
  • Ticker: CRDA
  • Exchange: LSE
  • Founded: 1925
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: UK£12.814b
  • Shares outstanding: 138.41m
  • Website: https://www.croda.com

Number of Employees


Location

  • Croda International Plc
  • Cowick Hall
  • Snaith
  • Goole
  • North Humberside
  • DN14 9AA
  • United Kingdom

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/25 17:48
End of Day Share Price2021/10/25 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.